Journal of Acute Disease (JAD), a publication of Hainan Medical University, is a bimonthly published medical journal dedicated to promoting and disseminating original, peer-reviewed work in the field of acute attack of all kinds of diseases, including pre-hospital and hospital emergency medicine, disaster medicine, critical diseases, acute diseases and related medical specialties by publishing high-quality scientific and clinical research worldwide. Original scientific researches, reviews, case reports, short communications, letter to editor related to the aim and scope of JAD are encouraged.
The journal's full text is available online at http://www.jadweb.org/. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.
Reviewers of JAD consist of members practicing in different professions from all over the globe. The journal is proud to have such an international and diverse editorial board that assists and facilitates the publications of articles which reflect a global view on acute diseases, and emphasize our focus on supporting the needs of medical practitioners.
As an international journal, JAD welcomes submissions from international contributors and researchers of all specialties. The journal provides a platform for reporting of acute diseases in different settings, which enhances our understanding of course, diagnosis, treatment and clinico-pathologic features of disease.
JAD allows us to seek opportunities to work with people who share our aim, and to enhance our work through partnership, and to uphold the standards of our profession and contribute to its advancement. We believe that in this way we can contribute to the development of treatment methods of acute diseases and emergency medicine.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, ProQuest, TDNet, Wanfang Data
The journal is indexed with, or included in, the following:
DOAJ, EMBASE/ Excerpta Medica, Emerging Sources Citation Index
Impact Factor® as reported in the 2022 Journal Citation Reports® (Clarivate Analytics, 2023): 0.5
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.